Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis K Antel, J Oosthuizen, F Malherbe, VJ Louw, MP Nicol, G Maartens, ... BMC infectious diseases 20, 1-8, 2020 | 32 | 2020 |
The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting K Antel, C Levetan, Z Mohamed, VJ Louw, J Oosthuizen, G Maartens, ... BMC cancer 19, 1-11, 2019 | 23 | 2019 |
Encephalopathy after persistent vomiting: Three cases of non-alcohol-related Wernicke's encephalopathy K Antel, N Singh, B Chisholm, JM Heckmann SAMJ: South African Medical Journal 105 (6), 442-443, 2015 | 21 | 2015 |
Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP KR Antel, E Panieri, N Novitzky South African Medical Journal 105 (5), 408-412, 2015 | 19 | 2015 |
Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein–Barr virus infection and survival S Cassim, K Antel, DR Chetty, J Oosthuizen, J Opie, Z Mohamed, ... Pathology 52 (4), 453-459, 2020 | 17 | 2020 |
CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients K Antel, D Chetty, J Oosthuizen, Z Mohamed, L Van der Vyver, ... Pathology 53 (5), 628-634, 2021 | 12 | 2021 |
Approach to lymphoma diagnosis and management in South Africa E Verburgh, K Antel South African Medical Journal 109 (10), 715-718, 2019 | 9 | 2019 |
Diagnosing lymphoma in the shadow of an epidemic: lessons learned from the diagnostic challenges posed by the dual tuberculosis and HIV epidemics K Antel, VJ Louw, G Maartens, J Oosthuizen, D Chetty, E Verburgh Leukemia & lymphoma 61 (14), 3417-3421, 2020 | 7 | 2020 |
In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes J Opie, K Antel, A Koller, N Novitzky Annals of hematology 99, 571-578, 2020 | 7 | 2020 |
Lymphadenopathy in a tuberculosis-endemic area: Diagnostic pitfalls and suggested approach K Antel, E Verburgh South African Medical Journal 109 (10), 712-714, 2019 | 7 | 2019 |
Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis and HIV-endemic region K Antel, J Oosthuizen, K Brown, F Malherbe, P Loebenberg, C Seaton, ... AIDS 37 (4), 587-594, 2023 | 2 | 2023 |
A Personalized Whole Genome-Informed Assay Targeting Single Mutant in Circulating Tumor DNA Can Identify MRD and Predict Relapse in DLBCL RW Merryman, J Rhoades, K Xiong, K Antel, HH An, RA Redd, ... Blood 142, 527, 2023 | 1 | 2023 |
The International Prognostic Score and HIV status predict red cell concentrate transfusion needs in Hodgkin lymphoma K Simba, Z Mohamed, JJ Opie, LF Andera, K Brown, J Oosthuizen, ... Leukemia & Lymphoma 64 (3), 613-620, 2023 | 1 | 2023 |
Lymphoma: Understanding the diagnostic challenges and improving outcomes in a TBand HIV-endemic area KR Antel | 1 | 2021 |
Comparison of whole‐genome and immunoglobulin‐based circulating tumor DNA assays in diffuse large B‐cell lymphoma RW Merryman, J Rhoades, K Xiong, RA Redd, K Antel, HH An, ... HemaSphere 8 (4), 2024 | | 2024 |
Genomic distinctions of HIV-and EBV-associated DLBCL in a diverse African cohort K Antel, A Nesmelov, MX Wu, C Slome, D Chetty, R Kriel, E Postovalova, ... Cancer Research 84 (6_Supplement), 786-786, 2024 | | 2024 |
Point of care ultrasound findings in critically ill SARS-COV2 patients in an HIV endemic, resourced constrained setting WM Jagga, B Biccard, J Bailly, A Esmail, K Antel, J Opie Heliyon 9 (6), 2023 | | 2023 |
Abstract A11: The international prognostic score and HIV status predict red cell concentrate transfusion need in Hodgkin Lymphoma ER Verburgh, K Simba, Z Mohamed, JJ Opie, K Brown, J Oosthuizen, ... Blood Cancer Discovery 3 (5_Supplement), A11-A11, 2022 | | 2022 |
In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes … J Opie, K Antel, A Koller, N Novitzky ANNALS OF HEMATOLOGY 99 (3), 579-579, 2020 | | 2020 |
BURKITT-LYMPHOMA AND BURKITT-LIKE LYMPHOMA/B-CELL LYMPHOMA UNCLASSIFIABLE WITH FEATURES INTERMEDIATE BETWEEN DIFFUSE LARGE B-CELL LYMPHOMA AND BURKITT LYMPHOMA: CLINICO … A Koller, K Antel, N Novitzky, J Opie INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY 41, 92-92, 2019 | | 2019 |